This federal contract award, valued at $10,465.69, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
The current contract award covers the procurement of GEMTESA 75 MG TABLET 90S, a medical product, with an ultimate completion date of December 30, 2024. The contract is a Firm Fixed Price (FFP) instrument, with no set-aside designation, indicating open competition. AmerisourceBergen, as the prime contractor, will be responsible for delivering the specified medical product to support federal government agencies, particularly military treatment facilities, veterans' healthcare programs, and other federal medical institutions.
Generated 3/28/25, 10:58 AM